{"id":"https://openalex.org/W2605048969","doi":"https://doi.org/10.1016/j.ejps.2017.03.049","title":"Cocrystal solubility product analysis \u2013 Dual concentration-pH mass action model not dependent on explicit solubility equations","display_name":"Cocrystal solubility product analysis \u2013 Dual concentration-pH mass action model not dependent on explicit solubility equations","publication_year":2017,"publication_date":"2017-04-07","ids":{"openalex":"https://openalex.org/W2605048969","doi":"https://doi.org/10.1016/j.ejps.2017.03.049","mag":"2605048969","pmid":"https://pubmed.ncbi.nlm.nih.gov/28392495"},"language":"en","primary_location":{"id":"doi:10.1016/j.ejps.2017.03.049","doi":"https://doi.org/10.1016/j.ejps.2017.03.049","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.ejps.2017.03.049","pdf_url":null,"source":{"id":"https://openalex.org/S119477091","display_name":"European Journal of Pharmaceutical Sciences","issn_l":"0928-0987","issn":["0928-0987","1879-0720"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-d","doyens","jufo-3","ki-jl-2","medline","norway-2","oarl","poland-100","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Pharmaceutical Sciences","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5078166589","display_name":"Alex Avdeef","orcid":"https://orcid.org/0000-0002-3139-5442","observed_orcids":["https://orcid.org/0000-0002-3139-5442"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Alex Avdeef","raw_affiliation_strings":["in-ADME Research, 1732 First Avenue #102, New York, NY 10128, USA. Electronic address: alex@in-ADME.com","in-ADME Research, 1732 First Avenue #102, New York, NY 10128, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"in-ADME Research, 1732 First Avenue #102, New York, NY 10128, USA. Electronic address: alex@in-ADME.com","institution_ids":[]},{"raw_affiliation_string":"in-ADME Research, 1732 First Avenue #102, New York, NY 10128, USA","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5078166589"],"corresponding_institution_ids":[],"apc_list":{"value":3070,"currency":"USD","value_usd":3070},"apc_paid":null,"fwci":1.499,"has_fulltext":false,"cited_by_count":26,"citation_normalized_percentile":{"value":0.80326804,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":90,"max":98},"biblio":{"volume":"110","issue":null,"first_page":"2","last_page":"18"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11881","display_name":"Crystallization and Solubility Studies","score":0.95169997215271,"subfield":{"id":"https://openalex.org/subfields/2505","display_name":"Materials Chemistry"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T11881","display_name":"Crystallization and Solubility Studies","score":0.95169997215271,"subfield":{"id":"https://openalex.org/subfields/2505","display_name":"Materials Chemistry"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10798","display_name":"Crystallography and molecular interactions","score":0.041999999433755875,"subfield":{"id":"https://openalex.org/subfields/1606","display_name":"Physical and Theoretical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":0.0017999999690800905,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cocrystals","display_name":"cocrystals","score":0.9350000023841858},{"id":"https://openalex.org/keywords/solubility-product","display_name":"solubility product","score":0.921999990940094},{"id":"https://openalex.org/keywords/eutectic-point","display_name":"eutectic point","score":0.6349999904632568},{"id":"https://openalex.org/keywords/solid-suspension","display_name":"solid suspension","score":0.382999986410141},{"id":"https://openalex.org/keywords/chemical-speciation","display_name":"chemical speciation","score":0.7860000133514404},{"id":"https://openalex.org/keywords/ionic-strength","display_name":"ionic strength","score":0.6349999904632568},{"id":"https://openalex.org/keywords/carbamazepine","display_name":"carbamazepine","score":0.8169999718666077},{"id":"https://openalex.org/keywords/indomethacin","display_name":"indomethacin","score":0.9470000267028809},{"id":"https://openalex.org/keywords/nevirapine","display_name":"nevirapine","score":0.9990000128746033},{"id":"https://openalex.org/keywords/gabapentin","display_name":"gabapentin","score":0.9959999918937683},{"id":"https://openalex.org/keywords/3-hydroxybenzoic-acid","display_name":"3-hydroxybenzoic acid","score":0.8169999718666077},{"id":"https://openalex.org/keywords/cinnamic-acid","display_name":"cinnamic acid","score":0.7540000081062317},{"id":"https://openalex.org/keywords/p-aminobenzoic-acid","display_name":"p-aminobenzoic acid","score":0.8560000061988831},{"id":"https://openalex.org/keywords/salicylic-acid","display_name":"salicylic acid","score":0.878000020980835},{"id":"https://openalex.org/keywords/saccharin","display_name":"saccharin","score":0.9089999794960022},{"id":"https://openalex.org/keywords/bioavailability","display_name":"bioavailability","score":0.9580000042915344}],"concepts":[{"id":"https://openalex.org/C100687433","wikidata":"https://www.wikidata.org/wiki/Q5139913","display_name":"Cocrystal","level":4,"score":0.9683715105056763},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.7979884147644043},{"id":"https://openalex.org/C155574463","wikidata":"https://www.wikidata.org/wiki/Q170731","display_name":"Solubility","level":2,"score":0.6840678453445435},{"id":"https://openalex.org/C56566620","wikidata":"https://www.wikidata.org/wiki/Q863829","display_name":"Solubility equilibrium","level":3,"score":0.4993407726287842},{"id":"https://openalex.org/C45904493","wikidata":"https://www.wikidata.org/wiki/Q912807","display_name":"Active ingredient","level":2,"score":0.47795796394348145},{"id":"https://openalex.org/C2779147919","wikidata":"https://www.wikidata.org/wiki/Q191381","display_name":"Saccharin","level":2,"score":0.4680454730987549},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.3866598606109619},{"id":"https://openalex.org/C21951064","wikidata":"https://www.wikidata.org/wiki/Q899212","display_name":"Combinatorial chemistry","level":1,"score":0.35108834505081177},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.0},{"id":"https://openalex.org/C112887158","wikidata":"https://www.wikidata.org/wiki/Q169324","display_name":"Hydrogen bond","level":3,"score":0.0},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.0},{"id":"https://openalex.org/C32909587","wikidata":"https://www.wikidata.org/wiki/Q11369","display_name":"Molecule","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000077206","descriptor_name":"Gabapentin","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000588","descriptor_name":"Amines","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D002220","descriptor_name":"Carbamazepine","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D002626","descriptor_name":"Chemistry, Pharmaceutical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003460","descriptor_name":"Crystallization","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003509","descriptor_name":"Cyclohexanecarboxylic Acids","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D004355","descriptor_name":"Drug Stability","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005680","descriptor_name":"gamma-Aminobutyric Acid","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006863","descriptor_name":"Hydrogen-Ion Concentration","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007213","descriptor_name":"Indomethacin","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D008958","descriptor_name":"Models, Molecular","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D008968","descriptor_name":"Molecular Conformation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009994","descriptor_name":"Osmolar Concentration","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012995","descriptor_name":"Solubility","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013816","descriptor_name":"Thermodynamics","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019829","descriptor_name":"Nevirapine","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.ejps.2017.03.049","doi":"https://doi.org/10.1016/j.ejps.2017.03.049","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.ejps.2017.03.049","pdf_url":null,"source":{"id":"https://openalex.org/S119477091","display_name":"European Journal of Pharmaceutical Sciences","issn_l":"0928-0987","issn":["0928-0987","1879-0720"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-d","doyens","jufo-3","ki-jl-2","medline","norway-2","oarl","poland-100","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Pharmaceutical Sciences","raw_type":"journal-article"},{"id":"pmid:28392495","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/28392495","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":51,"referenced_works":["https://openalex.org/W67800444","https://openalex.org/W658689627","https://openalex.org/W852900985","https://openalex.org/W962784527","https://openalex.org/W1503460358","https://openalex.org/W1576847877","https://openalex.org/W1849331108","https://openalex.org/W1911849308","https://openalex.org/W1964201664","https://openalex.org/W1976544366","https://openalex.org/W1979931965","https://openalex.org/W1982315739","https://openalex.org/W1990608904","https://openalex.org/W1996543935","https://openalex.org/W1998390903","https://openalex.org/W2006011804","https://openalex.org/W2010182430","https://openalex.org/W2010390876","https://openalex.org/W2013568325","https://openalex.org/W2020722862","https://openalex.org/W2026194834","https://openalex.org/W2035423152","https://openalex.org/W2040050274","https://openalex.org/W2041491704","https://openalex.org/W2048774593","https://openalex.org/W2049095253","https://openalex.org/W2056301544","https://openalex.org/W2056706988","https://openalex.org/W2061263372","https://openalex.org/W2067722023","https://openalex.org/W2082697065","https://openalex.org/W2083563769","https://openalex.org/W2085875242","https://openalex.org/W2092912556","https://openalex.org/W2094895096","https://openalex.org/W2131396276","https://openalex.org/W2157024787","https://openalex.org/W2166502293","https://openalex.org/W2171319380","https://openalex.org/W2210213035","https://openalex.org/W2284836302","https://openalex.org/W2313844632","https://openalex.org/W2316619285","https://openalex.org/W2329490514","https://openalex.org/W2462341956","https://openalex.org/W2485283686","https://openalex.org/W2504265005","https://openalex.org/W3003898783","https://openalex.org/W4230082925","https://openalex.org/W4239750817","https://openalex.org/W4244692462"],"related_works":["https://openalex.org/W2791780662","https://openalex.org/W2166502293","https://openalex.org/W2085875242","https://openalex.org/W7062444851","https://openalex.org/W1996543935","https://openalex.org/W2893859114","https://openalex.org/W7135033537","https://openalex.org/W2550059769","https://openalex.org/W2284836302","https://openalex.org/W2979240312"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":5},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":5},{"year":2018,"cited_by_count":5}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2017-04-14T00:00:00"}